9989 — Sundrug Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeLarge CapHigh Flyer

Annual income statement for Sundrug Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	617,769	634,310	648,734	690,462	751,777
Cost of Revenue
Gross Profit	154,619	158,550	156,506	171,946	189,320
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	583,676	598,124	614,974	653,578	711,270
Operating Profit	34,093	36,186	33,760	36,884	40,507
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	34,648	37,188	34,675	37,710	41,261
Provision for Income Taxes
Net Income After Taxes	23,692	25,329	23,854	25,703	29,127
Net Income Before Extraordinary Items
Net Income	23,692	25,329	23,854	25,703	29,127
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	23,692	25,329	23,853	25,703	29,126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	217	223	204	222	252
Dividends per Share